Presidential candidate Hillary Clinton opposes a law she spearheaded while in the Senate. The law, now part of Obamacare, prevents cheaper versions of complex drugs from being sold for 12 years after Food and Drug Administration approval.
Clinton’s change in position coincides with a broader shift in among health care policymakers about how to regulate new specialty drugs, which can cost drug makers billions to develop and be expensive for patients.
Read Full Article »